Visualizing tumour self-homing with magnetic particle imaging

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Oncology

Background:

• Circulating tumor cells (CTCs) are engineered for targeted cancer therapy and monitored using imaging reporter genes.
• Pre-labeling cells with imaging probes offers higher sensitivity for detecting low cell numbers.
• Magnetic Particle Imaging (MPI) is an emerging technology for detecting superparamagnetic iron oxide nanoparticles.

Purpose of the Study:

• To evaluate the efficacy of MPI for detecting iron-labeled experimental CTCs.
• To assess the ability of MPI to visualize CTC homing to tumors in vivo.
• To quantify iron content and tumor volumes using MPI.

Main Methods:

• CTCs were labeled with micro-sized iron oxide particles (MPIOs).
• Labeled CTCs were administered via intra-cardiac injection in tumor-bearing mice.
• MPI was used for in vivo and ex vivo detection; immunohistochemistry validated results.

Main Results:

• MPI successfully detected systemically administered, iron-labeled CTCs in the mammary fat pad tumors.
• The technique allowed visualization of CTC self-homing to tumor sites.
• Correlation between MPI data, iron content, and tumor volumes was established.

Conclusions:

• MPI provides a sensitive method for detecting iron-labeled CTCs in vivo.
• This study demonstrates MPI's potential for tracking cell migration and homing in cancer models.
• MPI represents a promising tool for noninvasive monitoring in breast cancer research.